Ayana R Kumar

About

Currently working on developing nanoformulations to improve the bioavailability of phytochemicals for the site-specific delivery against hepatocellular carcinoma.

Employment

• Amrita Vishwa Vidyapeetham Ph. D Scholar
  2019 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Translational progress of stimulus-responsive smart nanocarrier platforms for cancer theranostics: a review
  Ayana R. Kumar, Adithya Jayaprakash Kamath, Aina Ann Joseph +4 more
  Cancer Nanotechnology 2026 DOI: 10.1186/s12645-026-00395-w
  +Save
• PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials
  Scientific Reports 2026 DOI: 10.1038/s41598-026-51900-5
  +Save
• Emerging Role of Plant-Derived Products in Immunotherapy: Plausible Exposition for HCC Treatment
  Liver Cancer and Phytomedicine 2025 DOI: 10.1142/9789811293320_0011
  +Save
• Smart Polymer‐Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review
  Adithya Jayaprakash Kamath, Asawari Dilip Donadkar, Bhagyalakshmi Nair +5 more
  Phytotherapy Research 2025 DOI: 10.1002/ptr.8394
  +Save
• Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
  Sunil Kumar Sah, S.A. Ajay, Asawari Dilip Donadkar

  +8 more

  • Adithya Jayaprakash Kamath
  • Aswathy R. Devan
  • Rahul Soman
  • Ayana R. Kumar
  • Ashok R Unni
  • +3 more
  International Journal of Pharmaceutics 2025 DOI: 10.1016/j.ijpharm.2025.125261
  +Save
• An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma
  Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair +5 more
  Molecular Biotechnology 2024 DOI: 10.1007/s12033-023-00890-0
  +Save
• Chimeric Antigen Receptor (CAR) - T Cells Based Cancer Immunotherapy: Harnessing the Potential of Nanobiotechnology
  Anjana Menon, Ayana R. Kumar, Mahima Bharathi

  +4 more

  • Adithya Jayaprakash Kamath
  • Asawari Dilip Donadkar
  • M. S. Sudheesh
  • Lekshmi R. Nath
  Nanotechnology Based Strategies for Cancer Immunotherapy 2024 DOI: 10.1007/978-981-97-7022-9_9
  +Save
• Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances
  European journal of medical research 2024 DOI: 10.1186/s40001-024-02072-3
  +Save
• Green Synthesized Nanoparticles as a Plausible Therapeutic Strategy Against Hepatocellular Carcinoma: An Update on its Preclinical and Clinical Relevance
  Gopika Chandrababu, Sunil Kumar Sah, Ayana R. Kumar +2 more
  Recent Patents on Anti-Cancer Drug Discovery 2022 DOI: 10.2174/1574892817666220523124437
  +Save
• Decoding the mechanism of drugs of heterocyclic nature against hepatocellular carcinoma
  Sinoy Sugunan, Lekshmi R. Nath, Ayana R. Kumar +3 more
  Anti-Cancer Agents in Medicinal Chemistry 2022 DOI: 10.2174/1871520622666220418115310
  +Save
• Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma
  Lekshmi R. Nath, Ayana R. Kumar, Aswathy R. Devan +2 more
  Current Cancer Drug Targets 2022 DOI: 10.2174/1568009622666220317090552
  +Save
• An insight into the role of telmisartan as PPAR-γ/α dual activator in the management of nonalcoholic fatty liver disease
  Aswathy R. Devan, Bhagyalakshmi Nair, Ayana R. Kumar +1 more
  Biotechnology and Applied Biochemistry 2022 DOI: 10.1002/bab.2123
  +Save
• Unravelling the Immune Modulatory Effect of Indian Spices to Impede the Transmission of COVID-19: A Promising Approach
  Aswathy R. Devan, Bhagyalakshmi Nair, Ayana R. Kumar +3 more
  Current Pharmaceutical Biotechnology 2022 DOI: 10.2174/1389201022666210216144917
  +Save
• Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
  Molecular Biology Reports 2021
  +Save
• Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance
  M. Murali, Ayana R. Kumar, Bhagyalakshmi Nair +4 more
  Clinical and Translational Oncology 2021 DOI: 10.1007/s12094-021-02707-5
  +Save
• Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
  Aswathy R. Devan, Ayana R. Kumar, Bhagyalakshmi Nair

  +5 more

  • Nikhil Ponnoor Anto
  • Amitha Muraleedharan
  • Bijo Mathew
  • Hoon Kim
  • Lekshmi R. Nath
  Pharmaceuticals 2021 DOI: 10.3390/ph14070656
  +Save
• Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review
  Jasmine Baby, Aswathy R. Devan, Ayana R. Kumar +4 more
  Journal of Food Biochemistry 2021 DOI: 10.1111/jfbc.13761
  +Save
• Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment.
  Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair

  +1 more

  • Lekshmi R. Nath
  Current drug targets 2021 DOI: 10.2174/1389450122666210203194036
  +Save
• Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
  Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair +2 more
  Molecular Biology Reports 2021 DOI: 10.1007/s11033-021-06752-9
  +Save